Taking The ‘O’ Out Of RTOR: US FDA’s Real-Time Review Primed For Expansion Beyond Oncology

 
• By Sue Sutter
road to horizon
US FDA could look to broaden the horizons of its Real-Time Oncology Review program. • Source: Shutterstock

More from Real-World Evidence

More from Clinical Trials